secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001640334-26-000395
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences effects 1-for-3 reverse stock split effective March 10, 2026
-------------------------------------------------------------------------------

- Reverse split ratio 1-for-3; outstanding shares reduced from 2,124,772 to ~708,258.
- Effective at market open on March 10, 2026; new CUSIP 04301G706.
- No fractional shares issued; holders otherwise entitled to fractional share receive one whole share.
- All outstanding warrants and other derivatives adjust automatically per their terms.
- Board approved without stockholder vote under Nevada Revised Statutes 78.207.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-000395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer